Globus Medical (GMED) Restructuring Costs (2015 - 2026)

Globus Medical (GMED) has 12 years of Restructuring Costs data on file, last reported at $6.4 million in Q1 2026.

• For the quarter ending Q1 2026, Restructuring Costs rose 503.31% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $47.6 million (up 68.59% YoY), and the FY2025 full-year result was $42.3 million, up 42.88% from the prior year.
• Restructuring Costs for Q1 2026 stood at $6.4 million, down from $10.8 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $68.1 million in Q4 2023 and bottomed at -$3.6 million in Q3 2024.
• The 5-year median for Restructuring Costs is $4.2 million (2022), against an average of $12.0 million.
• The widest annual swing landed in 2022, when Restructuring Costs slumped 279.61%; it then surged 7097.7% in 2023.
• A 5-year view of Restructuring Costs shows it stood at $4.2 million in 2022, then jumped by 1531.68% to $68.1 million in 2023, then slumped by 74.9% to $17.1 million in 2024, then sank by 36.65% to $10.8 million in 2025, then plunged by 41.1% to $6.4 million in 2026.
• The last three Restructuring Costs figures came in at $6.4 million (Q1 2026), $10.8 million (Q4 2025), and -$2.7 million (Q3 2025), per Business Quant data.

Peer Comparison